Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Asian shares slip on trade worries, oil gives up some gains

Jun 25, 2018

By Hideyuki SanoTOKYO (Reuters) - Asian shares fell on Monday on escalating trade tensions between the United States and major economies while oil prices gave up some of their hefty gains made after major oil producers agreed to a modest increase in production.S&P500 mini futures eased as much as 0.6 percent in early trade while MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.25 percent. Japan's Nikkei lost 0.4 percent.The falls were triggered by a report from the Wall Street Journal that U.S. President Donald Trump plans to bar many Chinese companies from investing in U.S. technology firms and...

NZ central bank set to keep low rates as growth slows, trade woes cloud outlook

Jun 25, 2018

By Leika KiharaWELLINGTON (Reuters) - New Zealand's central bank is set to keep interest rates on hold this week and signal that no monetary tightening is on the cards in the near-term, with inflation subdued and escalating global trade friction clouding the outlook for an already slowing economy.All 16 economists polled by Reuters expect the Reserve Bank of New Zealand (RBNZ) to hold rates at 1.75 percent at its rate review on Thursday.Markets are on the lookout for any tweak governor Adrian Orr - who took on the job in March with a pledge to simplify the RBNZ's communication -...

Buoyant euro keeps dollar off 11-month highs, trade issues in focus

Jun 25, 2018

By Shinichi SaoshiroTOKYO (Reuters) - The buoyant euro kept the dollar from hitting an 11-month high on Monday, with trade issues between the United States and the European Union seen deciding the near-term direction for the currencies.The euro was 0.05 percent higher at $1.1662 after gaining about 0.5 percent on Friday. The single currency was lifted after Friday's upbeat German and French business activity data and fresh assurances by Italian politicians that their nation would not leave the single currency.The dollar index against a basket of six major currencies stood at 94.515 having retreated from 95.529, its highest level since...

New Zealand leader leaves hospital 3 days after giving birth

Jun 25, 2018

WELLINGTON, New Zealand — New Zealand Prime Minister Jacinda Ardern and her partner have named their baby daughter Neve and say they want her to grow up in a world in which she can make choices about her family and career based on what she wants. Ardern made her first public appearance on Sunday since giving birth to her daughter on Thursday. She answered a few questions from reporters while holding her baby at Auckland City Hospital before she planned on returning home. She will take six weeks of leave before returning to work. Ardern is just the second elected...

Against the grain: Australian banks face rural lending reckoning

Jun 25, 2018

By Byron KayeSYDNEY (Reuters) - Australian potato farmer Tom Fox says he had never missed a bank payment in two decades before a delay sending a shipment to Indonesia during a trade dispute between the countries prompted his lender to force him into receivership in 2013."I got a letter from the bank lawyers saying I had 12 hours to come up with A$2.4 million ($1.8 million), and that was an impossibility to do on that notice," Fox told Reuters.A third-generation farmer who built up the country's biggest seed potato producer, Fox said his farm and equipment were sold below value...

Stock Markets

About Us

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

Contact us: sales[at]themorningherald.com

Subscribe Now!